NCT00000300

Feasibility Study of Take-Home LAAM Medication - 3

Feasibility Study of Take-Home LAAM Medication

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (planned)
• Sponsor: University of California, Los Angeles · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to test therapeutic benefits of take-home LAAM. (1) Do subjects with take-home LAAM availability show increased clinical responsibility over subjects without; (2) Do subjects with take-home LAAM attempt diversion when random recall and other diversion safeguards are used; (3) Does treatment response correlate with background or drug use variables at intake, discharge, or during treatment?

Detailed description

1-Year study, participant will be randomly assigned to one of two groups: One will have the opportunity to earn take-home doses by turning in a designated number of clean urines. Two will not have the opportunity to earn take-home doses. Clinic visits three times per week. Urine sample given at each visit.

Conditions

• Opioid-Related Disorders

Interventions

Type	Name	Description
DRUG	LAAM

Timeline

• Start date: 1995-03-01
• First posted: 1999-09-21
• Last updated: 2017-11-01

Locations

1 site across 1 country: United States